Insiders · GNMK

Eric Stier

Officer at GenMark Diagnostics, Inc. (GNMK)

Eric Stier has filed 6 insider reports with the SEC since January 2021, as officer at GenMark Diagnostics, Inc. (GNMK). Eric Stier made no open-market purchases or sales in the last 12 months. The latest filing, on April 22, 2021, reports sale back to the company and tender of shares in a change of control at GenMark Diagnostics, Inc. (GNMK).

Filings
6
Companies
1
Bought on market
None
Sold on market
$422K

Companies where Eric Stier is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
GenMark Diagnostics, Inc. logo
GNMK
GenMark Diagnostics, Inc.
Officer0$422KApr 22, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Stier with

Questions about Eric Stier

What is Eric Stier's role at GenMark Diagnostics, Inc.?
Eric Stier reports to the SEC as officer at GenMark Diagnostics, Inc. (GNMK), according to the latest filing on April 22, 2021.
Has Eric Stier bought or sold stock recently?
The most recent open-market sale was on January 25, 2021: sold 29,658 shares of GenMark Diagnostics, Inc. (GNMK) for $422K at an average of $14.22.
How do I get alerts when Eric Stier files?
Follow Eric Stier on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Stier (SEC CIK 0001576821). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR · Get this as JSON